Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multi-Modal, Machine Learning-Driven Framework Integrating Multi-Omics for Personalized Chronic Kidney Disease Management.

Journal of clinical medicine·2026

Same author

Atlas of glomerular disease-specific genetic effects on blood transcriptome.

medRxiv : the preprint server for health sciences·2026

Same author

Mechanisms of the Indirect Effects of CMV Infection in Solid Organ Transplant Recipients: A Narrative Review.

Journal of clinical medicine·2026

Same author

Post-Transplant Hypertension in Kidney Recipients: Current Knowledge, Gaps and Future Directions.

Journal of clinical medicine·2026

Same author

Cardiorenal Syndrome in a Kidney Transplant Recipient With High-Flow Arteriovenous Fistula and Mycotic Pneumonia.

Cureus·2026

Same author

Induction of Clinical Operational Tolerance Through Immunosuppression Minimization: Less Is More?

Liver international : official journal of the International Association for the Study of the Liver·2026

Search research articles

Related Experiment Video

Updated: May 15, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

Cell therapies for immune-mediated disorders.

Natalia Wiewiórska-Krata^1,2, Bartosz Foroncewicz^2,3, Krzysztof Mucha^2,3,4

¹Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.

Frontiers in Medicine

|April 10, 2025

Summary

New cellular therapies, including hematopoietic stem cells (HSCs) and CAR T cells, offer promising, personalized treatments for immune-mediated disorders. These living drugs aim to safely and effectively rebalance the immune system, potentially leading to lasting remission.

Keywords:

Treg cells cell therapies immune disorders regenerative medicine transplantation

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Related Experiment Videos

Last Updated: May 15, 2025

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy

Published on: December 17, 2019

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Area of Science:

Immunology
Cellular Therapy
Genetic Engineering

Background:

Immune-mediated disorders are increasing globally, presenting diagnostic and therapeutic challenges.
Current treatments often yield unsatisfactory results or severe side effects.
Emerging cellular therapies utilize genetically engineered cells as 'living drugs'.

Purpose of the Study:

To review recent advances in cellular therapies for immune-mediated disorders.
To highlight novel treatments targeting exaggerated immune responses.
To discuss the potential of cell-based therapies for personalized medicine.

Main Methods:

Review of current literature on cellular therapies.
Focus on hematopoietic stem cells (HSCs), mesenchymal stromal cells (MSCs), regulatory T cells (Tregs), and chimeric antigen receptor (CAR) T cells.
Analysis of therapeutic potential for immune dysregulation.

Main Results:

Cellular therapies show potential for targeted, safe, and durable treatment of immune-mediated disorders.
These therapies offer personalized approaches to rebalancing the immune system.
Various cell types are being explored for their immunomodulatory capabilities.

Conclusions:

Cellular therapies represent a significant advancement in treating immune-mediated disorders.
These novel treatments may provide lasting remissions with reduced burden.
Future applications promise improved patient quality of life through advanced immune system regulation.